Opportunity Analysis

Deciding whether to enter the Australian market?

Hahn Healthcare can utilise its resources to help you determine the commercial viability of entering the Australian pharmaceutical market.

We can help you identify the market opportunity by performing any, or all, of the following:

• Market analysis: determining the size of the opportunity, leverage point growth, capabilities to serve, strength vs competition, relative gain vs competition;
• Identifying barriers to entry: cost, regulatory requirements, pricing & reimbursement;
• Determining project timelines: how long it will take to enter the market and start making a return on investment;
• Business case creation;
• Resource solution / identification;
• Implementation / delivery.

Once complete, you will have all the information required to quantify the opportunity and identify what resources are required to maximise it. 

Why enter the Australian Market?

International parties should look at the Australian market because:

• Pharmaceutical market is reimbursed;
• GDP per capita is number 1 in Asia Pacific;
• Health spend is high;
• Government promotes generic drugs;
• Geographically you can set and forget;
• Asia Pacific base.

Hahn Healthcare are committed to maximising assets locally. We are focused on the Australian market and will work closely with local and international companies to ensure they maximise the opportunities that exist here in Australia.